Purpose. To explore an epitope-based vaccine against Staphylococcus aureus, we screened the epitopes in the N2N3 subdomain of fibronectin-binding protein A (FnBPA) as a surface component of S. aureus.
INTRODUCTION
Staphylococcus aureus is an opportunistic bacterial pathogen that causes a broad spectrum of diseases, including superficial skin lesions, life-threatening invasive infections, pneumonia, endocarditis, osteomyelitis in humans and mastitis in cattle [1] [2] [3] . Currently, because of widespread antibiotics abuse, multidrug-resistant S. aureus infections are increasing in many countries and regions [4] [5] [6] . Therefore, vaccination is a logical and promising strategy to prevent S. aureus infection, which will be sorely needed [7] . So far, no S. aureus vaccine is available in the human clinic, and the few conventional vaccines, such as inactivated vaccines using killed bacteria or live-attenuated bacteria, that are available for cattle have shown unsatisfactory efficacy [8, 9] .
No licensed prophylactic or therapeutic vaccines against S. aureus are currently available.
Epitope-focused vaccines are increasingly being evaluated for the development of new vaccines against stubborn bacterial or viral infections, including tuberculosis, malaria and Salmonella enterica, where conventional vaccines have not been able to induce protective immune responses [10] [11] [12] , In addition, epitope vaccines can operate easily via their pathway of antigen processing and presentation and they are capable of eliciting desired and effective immune responses. Epitope vaccines also offer a number of advantages over conventional ones, such as reducing the production of extraneous antibodies and decreasing the potential for cross-reactivity, which may also trigger the incidence of autoimmune disease [13] [14] [15] . Currently, it has been indicated that a few epitope-based vaccines are available for various infectious diseases, including tuberculosis [16] and Neisseria meningitidis infection [17] , but no epitope vaccine against S. aureus infection has been successfully developed.
S. aureus possesses dozens of virulence molecules that are anchored on the microbial surface or secreted to extracellular space [18] , and these help it to adapt to a variety of host niches and establish diverse infections. The surface fibronectin-binding protein A (FnBPA) has been implicated in S. aureus infection [19, 20] . The N-terminus of FnBPA (A domains) was predicted to fold into three sub-domains, N1, N2 and N3, similar to clumping factor A (ClfA) [21] . Previous studies demonstrated that FnBPA played an important role during S. aureus infection, while the N2N3 sub-domain can bind fibrinogen and elastin and promote biofilm formation [22] [23] [24] [25] . Thus, the N2N3 sub-domain has been studied as a potential vaccine candidate.
In this work, we aimed to gain an insight into the anti-N2N3 subdomain humoral response and further map N2N3 epitopes in detail. The N2N3 subdomain was expressed by a prokaryotic system, purified and used to immunize BALB/c mice. In total, we acquired 10 hybridoma cell lines secreting monoclonal antibodies (mAbs) against N2N3. Finally, a linear B-cell epitope of the 3C3 mAb was confirmed. We evaluated the epitope's ability to stimulate the immune response in mice and assessed its immunoprotectivity against S. aureus.
METHODS
Animals and bacterial strains SPF female BALB/c mice (6-8 weeks of age) were purchased from the Experimental Animal Center, Harbin Veterinary Research Institute of the Chinese Academy of Agricultural Sciences (Harbin, People's Republic of China). S. aureus strain Newman and Escherichia coli strain BL21 were stored in our laboratory. The S. aureus strain Newman was grown in tryptic soy broth (TSB). E. coli strain BL21 was grown in Luria-Bertani (LB) broth at 37 C in the presence of 50 mg ml À1 ampicillin when necessary.
Expression of N2N3 proteins
Genomic DNA was extracted from S. aureus strain Newman and used as the PCR template. Based on the n2n3 gene sequence in GenBank (GenBank accession number: 003899.1), a pair of specific primers was designed. Restriction sites (underlined below) were added at the beginning end of the primers. The primer sequences are shown below. Forward primer: 5¢-ggatccggtacagatgtaacaagtaaag-3¢ (BamHI). Reverse primer: 5¢-aagcttatttttcccatttccgtt-3¢ (HindIII). A 954-bp fragment of n2n3 was amplified by the PCR method. Doubledigested PCR products were inserted into the pET-32a(+) plasmid, and the pET-32a(+)-n2n3 plasmids were transformed into E. coli strain BL21 (DE3), and then the recombinant bacteria were induced to express N2N3 proteins by 1 µg µl À1 IPTG. After 4 h induction, the recombinant bacteria were collected by centrifugation and resuspended in phosphate-buffered saline (PBS); the suspension was then sonicated. The supernatant was harvested and incubated with nickel-nitrilotriacetic acid (Ni-NTA) resin affinity chromatography (Qiagen). 
ELISA
To evaluate the immune reactions of the N2N3 protein with the mAbs, an indirect ELISA was established as described previously [26] . Briefly, the ELISA plate was coated with N2N3 protein (200 ng/well) and incubated overnight at 4 C, followed by blocking with 5 % skimmed milk for 2 h at room temperature. After washing, the plate was incubated with the obtained mAbs for 5 h at 4 C and washed thoroughly before horseradish peroxidase (HRP)-conjugated goat anti-mouse IgG (Sigma-Aldrich) was added into the wells at a dilution of 1 : 5000. The reaction was developed with tetramethylbenzidine (TMB; Sigma-Aldrich) and the OD 450 was detected by an automated ELISA plate reader (Bio-Rad). Finally, the positive reactivity was defined as threefold higher absorbance than background.
Screening of mAbs-binding phage with a random peptide library
Phage biopanning was used in the assay as described previously [27] . Briefly, the prepared mAbs (100 µg ml
À1
) were coated in the ELISA plate and incubated overnight at 4 C and, after being washed with TBST (PH7.5) buffer six times, the plate was blocked for 1 h at 4 C. After washing, the diluted solution from 10 µl of the original phage library (phage display 12 peptide library kit, Ph.D.-12) (NEB, Beverly, MA, USA) was added into the wells and incubated for 1 h at room temperature. After being washed again, the bound phage was eluted and subsequently amplified in early-log-phase E. coli ER2738 cells. After three rounds of biopanning had been carried out according to the manufacturer's instructions, 10-15 individual blue phage clones were chosen and analysed for target binding by phage ELISA. To confirm which B epitope motif reacts with mAbs, the positive phage clones were sequenced (Jinweizhi Biotech Co, Beijing, People's Republic of China). The corresponding amino acid sequences were confirmed according to the inserted nucleotide sequences and compared with the amino acids of N2N3 proteins to find consensus sequences using the MegAlign program of Lasergene 7.1.
Phage ELISA
To confirm which B epitope motif reacts with mAbs, the binding of selected phages to mAbs was evaluated by ELISA to identify the affinity and specificity [28] . Briefly, ELISA plates were coated with the prepared mAbs (10 µg ml À1 ) in buffer [0.1M NaHCO3 (PH8.6)] and incubated overnight at 4 C. BSA protein was chosen as a control. After being washed with TBST, 100 µL (10 11 p.f.u. ml
À1
) purified phages was added into the wells and incubated for 2 h at room temperature. After being washed with TBST, bound phages were analysed with horseradish peroxidase (HRP)-conjugated anti-M13 antibody (NEB, Beverly, MA, USA) with TMB as the substrate. Finally, the optical densities (OD 450nm ) at 450 nm were detected on an automated ELISA plate reader. The positive phage was determined according to a ratio of experimental well OD 450nm /control well OD 450nm of greater than 2.1.
Analysis of mAbs binding to S. aureus
In order to evaluate the immunocompetence of the screening mAbs, an indirect immunofluorescence assay was performed. Briefly, the inactivated S. aureus were fixed on the microslide. After being blocked with 5 % skimmed milk, the microslides were incubated with screening mAbs, mice serum against N2N3 and mAbs against GapC1 as a control, respectively, overnight at 4 C. After washing, FITC-conjugated goat anti-mouse IgG was added on the microslide and incubated for 5 h at 4 C. Finally, the reaction was detected using a confocal microscope.
Assay for S. aureus adherence
To determine whether the screening mAbs can block S. aureus binding to fibrinogen (Fn) of immobilization. Briefly, ELISA plates were coated by using the Fn (10 µg ml À1 , Sigma-Aldrich) overnight at 4 C. After being sealed with 5 % skimmed milk, the plates were incubated with S. aureus (2.5Â10 7 p.f.u./well) previously treated with different concentrations of screening mAbs, or 5B7 mAbs (5, 10, 15 µg ml À1 ) against GapC 1 as a control, for 1 h at 37 C, respectively, with three duplications for each group. After being washed with PBST, the mice sera against S. aureus were added into the plate for 1 h at 37 C. After washing, the reactions were detected with horseradish peroxidase (HRP)-conjugated goat anti-mouse IgG and TMB as a substrate. Finally, the optical densities at 450 nm were measured on an automated ELISA plate reader.
Homology analysis
The amino acid sequences of the identified epitopes were compared with the FnBPA sequence of different S. aureus strains on GenBank to verify the homology.
Immunogenicity of B cell epitopes
To determine the crucial amino acids of the screening B-cell epitope, each amino acid residue of the epitope was substituted with alanine, and then a series of complementary oligonucleotides coding for the mutated versions of the epitope motif with added restriction endonuclease BamHI and XholI sites on both ends were synthesized and inserted into pGEX-6p-1 vector, before the recombinant plasmids were expressed with the desired epitopes by E.coli BL21 (DE3). The expressed epitopes were then analysed by SDS-PAGE. The key amino acids of the antigen epitope performing vital immunogenicity were evaluated by Western blot. Briefly, the recombinant proteins were transferred onto nitrocellulose membranes, and then the membranes were incubated overnight at 4 C with the screening mAbs (1 : 3000 dilution). After extensive washing, the HRP-conjugated rabbit anti-mice IgG antibodies (1 : 5000 dilution) were further incubated. Finally, the reaction was determined by a detection system.
Immunization and challenge infection
Six-to-eight-week-old SPF female BALB/c mice were immunized three times at 14-day intervals with PBS alone, FnBPA alone, epitope/GST and GST protein plus complete Freund's adjuvant at primary immunity or incomplete Freund's adjuvant (Sigma) at boost immunity. There were 15 mice in each group, with 100 µg protein per mouse being administered by intramuscular injection. Fourteen days after the third immunization, immune serum was collected from five mice from every group and the IgG titres in individual mouse serum samples were measured by ELISA. The cut-off value was determined as the mean+3 SD of the OD 450 value demonstrated by the negative serum. The serum sample was regarded as positive if the OD 450 value was higher than the cut-off value, otherwise it was regarded as negative, and the data represented the end-point dilution titres [29] . Other mice from every group were intraperitoneally injected with 1Â10 9 c.f.u. of S. aureus strain Newman to determine the survival rates. The survival rates were recorded for 14 days after infection.
Statistics
All statistical analyses were performed using an unpaired Student's t-test using SPSS 13.0 software. The data were presented as the means plus standard deviations from three independent experiments. P-values <0.05 were considered significant.
RESULTS

Expression and purification of N2N3 protein
The recombinant E. coli BL21 strain with the pET-32a (+) -N2N3 plasmid was induced for 4 h with IPTG and the N2N3 protein is shown in Fig. 1a . The SDS-PAGE result indicated that a specific protein band presented in the supernatant of the recombinant bacterial lysate with pET-32a (+) -N2N3 plasmid, but not in the one with pET32a(+) plasmid. The N2N3 was purified using a Ni-NTA method. The purified protein was validated with an FnBPA antibody by Western blot (Fig. 1a) .
Generation of mAbs
After the third immunization, spleen cells from mice immunized with N2N3 protein were fused to SP2/0 hybridoma cells in four 96-well plates. Indirect ELISA assay indicated that a total of 15 clones contained anti-N2N3 protein antibodies. Moreover, the supernatants of clones 1E9, 1E3, 3C3, 1H6, 4B5, 3D5, 3D6, 3E11, 3F11 and 4A5, which generated the strongest immune response, were again subcloned and selected for expansion in order to obtain stable mAbs. Finally, identification of the subtypes indicated that all mAbs were IgG1 subtypes containing k chains.
The ELISA results showed that the mAbs titres of the culture supernatants and ascites fluid were 1 : 320~1 : 640 and 1 : 128,000, respectively (Fig. 1b) . As shown in Fig. 1c , the Western blot results showed that the corresponding specific band was observed when the hybridoma supernatants of the above clones were used as the primary antibody, respectively, while for the SP2/0 myeloma cell supernatants used as a negative control no specific band was observed.
Mapping of the mAb epitopes
To map the epitopes of the N2N3 proteins recognized by 1E9, 1E3, 3C3, 1H6, 4B5, 3D5, 3D6, 3E11, 3F11 and 4A5 mAbs, biopanning of a phage-displayed 12 random peptide library was performed. After three successive rounds of biopanning, the screened phages were well enriched and the yield of positive phage clones showed an obvious increase (Table 1) . Forty positive phages from the biopanning of each mAb were selected at random and further screened by phage ELISA. The deduced amino acid sequences of the corresponding inserts of 10 different positive phages of each mAb were analysed and identified. The amino acid sequences that presented in more than three different selected clones and matched with N2N3 protein were confirmed. Finally, peptide-IETFNKANNRFSH-binding 3C3 mAbs only showed a good match with the N2N3 protein at 159-171 amino acids (Table 2) .
In vitro functional analyses of mAbs
The N2N3 mAbs bind S. aureus strongly An indirect immunofluorescence experiment was used to evaluate the ability of 3C3 mAbs to bind S. aureus. Briefly, the inactivated S. aureus was fixed on the microslide, and anti-FnBPA antibody, anti-GapC antibody and 3C3 mAbs served as the positive control, the negative control and the experimental group, respectively. Under confocal laser scanning microscope detection, as shown in Fig. 2a , the negative control group did not exhibit green fluorescence, while both the positive control group and the experimental group obviously exhibited green fluorescence around the bacteria in morphology, and the fluorescence was mainly located on the surface of the bacteria, which indicated 3C3 mAbs binding on the surface of the bacteria and epitopes against 3C3 mAbs being exposed on the S. aureus outer membrane.
The N2N3 mAbs inhibit S. aureus adherence to fibrinogen In the same amount of bacteria, the inhibited S. aureus adherence results showed that the absorbance values (OD 450nm ) in the group of the 3C3 mAbs experienced an obvious reduction in to comparison to those for the corresponding control group of 5B7 mAbs under 5, 10 and 15 µg ml À1 concentrations, respectively, which indicated that the 3C3 mAbs were able to block the adhesion between S. aureus and fibrinogen (Fig. 2b) .
Analysis of the B cell epitopes
Analyses of epitope homology To evaluate the homology of the identified epitope, the IETFNKANNRFSH sequences were aligned with those of the FnBPA protein from different S. aureus strains via NCBI BLAST. The results showed that the sequences are highly conserved in 13 S. aureus strains, while the homology was 100 % ( Table 3) .
Identification of the key amino acids among B epitopes
As shown in Fig. 3a Partial protection of N2N3 159-171 immunization against lethal S. aureus infection For the detection of antibody levels against screened epitopes in sera from immunized mice after 49 days, an antibody-capture ELISA was performed. These results show that the antibody titre in sera from the FnBPA-immunized mice was 1 : 128 000, while that from the N2N3 159-171 -GSTimmunized mice was 1 : 8000. The control sera from the GST and PBS-immunized mice were negative. These results clearly show that the N2N3 159-171 epitope is highly immunogenic in mice (Fig. 3b) .
To evaluate whether the N2N3 159-171 epitope can evoke immune protection against S. aureus infection, the immunized mice were challenged with S. aureus Newman 35 days after the third immunization. While the controls (GSTimmunized group and PBS-immunized group) all succumbed to infection, 70 % of the FnBPA-immunized group (positive control) and 40 % of the N2N3 159-171 -immunized group survived (Fig. 3c) . These results indicate that N2N3 159-171 can induce a protective immune response to reduce S. aureus infection in mice. Table 2 . Identification of peptide sequences from the positive phage clones bound by 3C3 mAbs mAbs Phage Sequence
The homologous amino acid residues of the epitope motif are underlined.
DISCUSSION
S. aureus has become a ubiquitous pathogen for humans and animals with high mortality. S. aureus can adhere to the host tissue through its adhesion molecules during the early stage of infection, and the fibronectin-binding protein (FnBPA) in particular can bind with extracellular matrix proteins and is capable of promoting S. aureus to invade cells, and thus is considered a potential vaccine candidate. The FnBPA DNA vaccine constructed by Su et al. was able to trigger humoral immunity and cellular immunity in mice effectively [30] . Subsequently, the serum from mice immunized with F1B110-263 of FnBPA immunodominant fragments has been able to induce opsonophagocytic killing of S. aureus in vitro, and kidneys from mice actively immunized with the recombinant vaccine effectively limited MRSA252 infection as compared to the control mice immunized with the alum adjuvant. Moreover, the mice vaccinated with the F1B 110-263 exhibited 53.3 % higher survival rates than the control group with aluminium adjuvant (6.7 % survival) [31] . These studies showed that FnBPA is highly immunogenic and can elicit effective immune responses. However, due to the large size of FnBPA (Mw of 106 kD), it is very difficult for it to be expressed to a high level, which limits FnBPA application. In recent years, epitope-based vaccines have received increasing attention. Therefore, an FnBPA-epitope-based vaccine may potentially elicit strong protective immune responses and could provide an important reference for S. aureus vaccines.
Phage display technology has been widely used for the screening of epitopes for monoclonal antibodies, and has been established as a powerful and high-throughput tool for the rapid mapping of epitopes [32, 33] . In this study, using phage display screening antigen epitope, after three biopannings the screened positive phages were cloned and sequenced; the obtained sequence was compared with the amino acid sequence of N2N3 and the matched continuous amino acid sequence was expressed and evaluated by Western blotting before a linear B cell epitope 159 IETFNKANNRFSH 171 was confirmed. To further evaluate the immune function of each amino acid within the epitope motif, each amino acid was individually mutated to alanine, and the Western blotting results showed that 164K/A, 167 N/A, 168R/A and 169F/A are critical for binding to 3C3 mAbs.
A common B cell epitope was present among the 10 mAbs for the following reasons Firstly, positive phages with low homology of N2N3 sequence could specifically bind mAb of 
Consensus NLNGSIETFNKANNRFSHVAFI
The homologous amino acid residues of the epitope motif are underlined. the N2N3 protein, but the epitope of this might be a conformational one. Secondly, during the screening, nonspecific phage amplification affected the selection of N2N3 epitopes. Finally, during the elution and operation process, phages of high and specific affinity might not be eluted. Whatever the case, the ELISA results showed that 3C3 mAb can react with S. aureus, and the results of the indirect immunofluorescence assay indicated that the group with 3C3 mAb and the positive control group showed green fluorescence, but the negative control did not show green fluorescence, and so they confirmed that the screening epitope was located on the surface of the bacteria.
Moreover, the indirect ELISA result showed that 3C3 mAb obviously inhibits the binding between S. aureus and fibrinogen, which indicates that screened epitopes of 3C3 mAbs could induce an immune response. Therefore, screened B cell epitopes of N2N3 might be located in the fibrinogenand elastin-binding regions. In addition, the results of the antibody detection from immune mice showed that a group of B cell epitopes can generate antibodies against FnBPA and that the antibody titre from serum from mice can reach 1 : 8 000. Importantly, the challenge assay indicated that the immune protective rate from a group of epitopes of 3C3 mAbs was 40 %, and although this is not very high, as for an epitope vaccine, the immune effect was exciting, and have been related to epitope exposure on the surface of S. aureus. Because S. aureus generates over 50 virulence factors to acclimatize itself to a variety of host niches and enable diverse infections [18] , a single antigen is not sufficient to prevent S. aureus infection. The synergy of multiple staphylococcal antigens or epitopes would likely result in a more effective vaccine. In a future study, by developing the polyvalent epitopes vaccine or emulsifying with the new adjuvants, such as CpG, poly (I : C) and the like, we will further increase the immunogenicity of the screened B-cell epitope. In addition, we will screen T-cell epitopes of the N2N3 protein, and this information will be important for further developing a S. aureus polyvalent epitopes vaccine.
Finally, the sequence alignment of the screened B-cell epitope was performed among different S. aureus strains, and the results showed that sequence homology was 100 %, which indicated that the epitope can resist infection from different S. aureus strains. Therefore, the screened B-cell epitopes can be used for an epitope-based vaccine against S. aureus infection.
Conclusion
Taken together, we have identified a novel highly conserved linear B-cell epitope in the N2N3 subdomain of S. aureus FnBPA protein. These data may provide an explanation for the FnBPA-induced immune response against S. aureus infection and highlight the possibility of developing an epitope-based vaccine candidate for S. aureus.
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